Skip to content

Post Market Clinical Follow Up of SkanRespiro Plus and Pranaa

A prospective, post market, non-interventional observational, open label, single arm, single center study to confirm clinical safety and performance of SkanRespiro Plus and Pranaa

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042810
Enrollment
60
Registered
2022-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified Health Condition 2: J953- Chronic pulmonary insufficiency following surgery Health Condition 3: J709- Respiratory conditions due to unspecified external agent Health Condition 4: J969- Respiratory failure, unspecified Health Condition 5: J689- Unspecified respiratory conditiondue to chemicals, gases, fumes and vapors

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Skanray Technologies Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult and pediatric subjects of age more than two year or body weight of 10 kg above whichever is lower and of either gender. Subjects who need mechanical ventilation. Subject or the legally authorised representative on behalf of subject shall be capable of understanding and signing the informed consent form.

Exclusion criteria

Exclusion criteria: Subjects with age less than two year or less than 10 kg of body weight. Subjects who need ventilation during transport. Pregnant or nursing mother. Unconscious subjects shall be excluded from the non invasive mode of ventilation.

Design outcomes

Primary

MeasureTime frame
Determining the performance in terms of delivered parameters against the intended or set values for the specific subject condition.Timepoint: Every 4 hours

Secondary

MeasureTime frame
Collection of feedback which includes investigator’s assessment of the overall safety and performance of the SkanRespiro Plus and Pranaa. Collection of feedback from the user reflecting the ease of ventilation and usability. The collection of evidence reflecting the subject ventilation Timepoint: Every seventh day or earlier

Countries

India

Contacts

Public ContactVasundhara R

Narayana Health MICU Mazumdar Shaw Medical Center

chethananudeeps@gmail.com9599204215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026